TY - JOUR
T1 - Hemodialysis access thrombosis
AU - Quencer, Keith Bertram
AU - Oklu, Rahmi
N1 - Publisher Copyright:
© 2017 Cardiovascular Diagnosis and Therapy.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.
AB - For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.
KW - AV access thrombosis
KW - Arteriovenous fistula (AVF)
KW - Arteriovenous graft (AVG)
KW - Pulse spray aided pharmacomechanical thrombolysis
UR - http://www.scopus.com/inward/record.url?scp=85038627803&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038627803&partnerID=8YFLogxK
U2 - 10.21037/cdt.2017.09.08
DO - 10.21037/cdt.2017.09.08
M3 - Review article
AN - SCOPUS:85038627803
SN - 2223-3652
VL - 7
SP - S299-S308
JO - Cardiovascular Diagnosis and Therapy
JF - Cardiovascular Diagnosis and Therapy
ER -